IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Defining Success in IBD: Treat-to-Target
Where Conventional IBD Therapies Fall Short
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Setting the Stage: Why Rethinking IBD Care Matters Now
Navigating IBD Guidelines: What Clinicians Need to Know Now
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Translating Advances into Practice: Lessons from Today’s IBD Landscape
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
IBD Beyond Symptoms: What Community GIs Need to Know
IBD Masterclass: Foundations of Pathophysiology and Targeted Therapy
Putting It All Together: Challenges Addressed
Remission: Can You Prove It?
David Rubin, MD
Kimberly D. Orleck, PA-C
Tailoring Treatment: Can You Select the Best Therapy?
Brooke Hodnick, PA-C, MPAS
Severity Assessment: Can You Pin the Stage on the Patient?
Jennifer Geremia, PA-C
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.